DLB · NYSE
Dolby Laboratories (DLB) Stock Price & Fundamentals
Dolby Laboratories (DLB) closed at $386.99 on Oct 9, 2026, up 1.82% from the previous close of $380.09.
Share price, past year
1Y −1.17%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $386.99 |
| Sep 30, 2026 | $381.99 |
| Aug 31, 2026 | $382.17 |
| Jul 31, 2026 | $329.59 |
| Jun 30, 2026 | $325.97 |
| May 29, 2026 | $332.08 |
| Apr 30, 2026 | $341.50 |
| Mar 31, 2026 | $352.34 |
| Feb 27, 2026 | $361.15 |
| Jan 30, 2026 | $350.74 |
| Dec 31, 2025 | $377.63 |
| Nov 28, 2025 | $364.87 |
| Oct 31, 2025 | $362.51 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 165.4
- EPS (TTM)
- $2.34
- Revenue (TTM)
- $1.35B
- Net income (TTM)
- $226.18M
- Shares outstanding
- —
- Dividend yield
- 0.36%
- 52-week range
- $314.21 – $391.57
Financials
Dolby Laboratories reported revenue of $1.35B for fiscal 2025, up 5.92% from fiscal 2024.
Dolby Laboratories earned net income of $255.02M in fiscal 2025, a net margin of 18.9%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Sep 26, 2025 | $1.35B | +5.9% | $255.02M | 18.9% | $2.62 | $435.85M |
| FY2024ended Sep 27, 2024 | $1.27B | −2.0% | $261.83M | 20.6% | $2.69 | $297.25M |
| FY2023ended Sep 29, 2023 | $1.30B | +3.7% | $200.66M | 15.4% | $2.05 | $336.74M |
| FY2022ended Sep 30, 2022 | $1.25B | −2.1% | $184.09M | 14.7% | $1.81 | $270.65M |
| FY2021ended Sep 24, 2021 | $1.28B | +10.3% | $310.23M | 24.2% | $2.97 | $393.30M |
| FY2020ended Sep 25, 2020 | $1.16B | −6.4% | $231.36M | 19.9% | $2.25 | $277.50M |
| FY2019ended Sep 27, 2019 | $1.24B | +17.7% | $255.15M | 20.6% | $2.44 | $231.39M |
| FY2018ended Sep 28, 2018 | $1.05B | −2.4% | $41.75M | 4.0% | $0.39 | $279.39M |
| FY2017ended Sep 29, 2017 | $1.08B | +5.3% | $206.48M | 19.1% | $2.00 | $278.18M |
| FY2016ended Sep 30, 2016 | $1.03B | — | $185.86M | 18.1% | $1.81 | $259.30M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2026ended Jun 26, 2026 | $305.00M | $28.60M | $0.30 |
| Q2 FY2026ended Mar 27, 2026 | $395.63M | $94.92M | $0.99 |
| Q1 FY2026ended Dec 26, 2025 | $346.71M | $53.33M | $0.55 |
| Q4 FY2025ended Sep 26, 2025 | $307.02M | $49.33M | $0.50 |
| Q3 FY2025ended Jun 27, 2025 | $315.55M | $46.07M | $0.48 |
| Q2 FY2025ended Mar 28, 2025 | $369.56M | $91.79M | $0.94 |
| Q1 FY2025ended Dec 27, 2024 | $357.00M | $67.82M | $0.70 |
| Q4 FY2024ended Sep 27, 2024 | $304.81M | $58.57M | $0.59 |
Company profile
- Name
- Dolby Laboratories, Inc.
- Ticker
- DLB
- Exchange
- NYSE
- Industry (SEC SIC)
- Patent Owners & Lessors
- Headquarters
- 1275 Market Street, San Francisco, CA 94103
- Incorporated in
- DE
- Fiscal year ends
- September
- SEC CIK
- 0001308547
Recent SEC filings
- Aug 27, 2026
- Jul 30, 2026
- Jul 30, 2026
- Apr 30, 2026
- Apr 30, 2026
- Feb 6, 2026
- Jan 29, 2026
- Jan 29, 2026
Frequently asked questions
What is Dolby Laboratories's stock price?
Dolby Laboratories (DLB) closed at $386.99 on Oct 9, 2026, up 1.82% from the previous close of $380.09.
How much revenue does Dolby Laboratories make?
Dolby Laboratories reported revenue of $1.35B for fiscal 2025, up 5.92% from fiscal 2024.
What is DLB's P/E ratio?
Dolby Laboratories's price-to-earnings ratio is 165.4, based on trailing twelve-month diluted EPS of $2.34.
Does Dolby Laboratories pay a dividend?
Yes. Dolby Laboratories declared $1.41 per share in dividends over the last four quarters, a yield of 0.36%.
Sources and methodology
Fundamentals come from Dolby Laboratories, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures